Page last updated: 2024-09-04

levofloxacin and Meningitis, Pneumococcal

levofloxacin has been researched along with Meningitis, Pneumococcal in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's8 (80.00)29.6817
2010's0 (0.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Cottagnoud, M; Cottagnoud, P; Schaffner, T; Stucki, A; Winkelmann, V1
Chen, YH; Chen, YS; Cheng, SH; Hsueh, PR; Ko, WC; Lee, CM; Lee, WS; Lee, YL; Lin, CN; Lin, CY; Liu, CP; Lu, MC; Lu, PL; Shao, PL; Sheng, WH; Shi, ZY; Tang, HJ; Tsai, YT; Tseng, SH; Wang, FD; Wang, LS; Wu, TS; Yen, MY1
Alqahtani, M; Ciccotelli, W; Cox, P; Low, D; Morris, S; Opavsky, M; Pillai, D; Poutanen, S1
Acosta, F; Cottagnoud, M; Cottagnoud, P; Entenza, J; Flatz, L; Kühn, F1
Acosta, F; Cottagnoud, M; Cottagnoud, P; Entenza, J; Flatz, L; Kühn, F; Stucki, A1
Cottagnoud, M; Cottagnoud, P; Entenza, J; Flatz, L; Kühn, F; Stucki, A1
Bennett, SP; Wortmann, GW1
Klugman, KP1
Dash, AK; Destache, CJ; Larsen, C; Owens, H; Pakiz, CB1
Baraldo, M; Furlanut, M; Giobbia, M; Pea, F; Scotton, PG; Vaglia, A1

Other Studies

10 other study(ies) available for levofloxacin and Meningitis, Pneumococcal

ArticleYear
Daptomycin produces an enhanced bactericidal activity compared to ceftriaxone, measured by [3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Bacteriolysis; Ceftriaxone; Cell Wall; Cerebrospinal Fluid; Choline; Daptomycin; Disease Models, Animal; Humans; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillin Resistance; Rabbits; Streptococcus pneumoniae; Treatment Outcome; Tritium

2007
Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2022, Volume: 55, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Doripenem; Drug Resistance, Bacterial; Ertapenem; Humans; Levofloxacin; Linezolid; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae; Taiwan; Vancomycin

2022
A new twist on an old problem: a case of pediatric meningitis caused by multidrug-resistant Streptococcus pneumoniae serotype 19A.
    Canada communicable disease report = Releve des maladies transmissibles au Canada, 2008, Volume: 34, Issue:11

    Topics: Anti-Bacterial Agents; Cefuroxime; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Infant; Levofloxacin; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae; Vancomycin

2008
Cefotaxime acts synergistically with levofloxacin in experimental meningitis due to penicillin-resistant pneumococci and prevents selection of levofloxacin-resistant mutants in vitro.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:8

    Topics: Animals; Anti-Infective Agents; Cefotaxime; Cephalosporins; DNA, Bacterial; Drug Resistance, Bacterial; Drug Synergism; Levofloxacin; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Mutation; Ofloxacin; Penicillin Resistance; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; Streptococcus pneumoniae

2003
Meropenem prevents levofloxacin-induced resistance in penicillin-resistant pneumococci and acts synergistically with levofloxacin in experimental meningitis.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2003, Volume: 22, Issue:11

    Topics: Animals; Disease Models, Animal; DNA, Bacterial; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Levofloxacin; Male; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Polymerase Chain Reaction; Rabbits; Reference Values; Sensitivity and Specificity; Streptococcus pneumoniae; Thienamycins

2003
Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Drug Synergism; Levofloxacin; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; Streptococcus pneumoniae

2004
Fatal meningitis due to levofloxacin-resistant Streptococcus pneumoniae.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 29, Issue:6

    Topics: Anti-Infective Agents; Drug Resistance, Microbial; Fatal Outcome; Humans; Levofloxacin; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pneumococcal Infections; Streptococcus pneumoniae

1999
Levofloxacin-resistant pneumococcus.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 31, Issue:2

    Topics: Anti-Infective Agents; Drug Resistance, Microbial; Humans; Levofloxacin; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae

2000
Cerebrospinal fluid penetration and pharmacokinetics of levofloxacin in an experimental rabbit meningitis model.
    The Journal of antimicrobial chemotherapy, 2001, Volume: 47, Issue:5

    Topics: Animals; Anti-Infective Agents; Area Under Curve; Disease Models, Animal; Levofloxacin; Meningitis, Pneumococcal; Ofloxacin; Rabbits; Streptococcus pneumoniae

2001
Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Nov-01, Volume: 33, Issue:9

    Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Female; Humans; Levofloxacin; Male; Meningitis, Escherichia coli; Meningitis, Meningococcal; Meningitis, Pneumococcal; Middle Aged; Ofloxacin

2001